Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poupart

Showing results (131-140 of 192) with videos related to

Pageof 20
Sort By:
Oncotarget|May 19, 2018
Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME scheduleAdeline Pêtre, Cécile Dalban, Andy Karabajakian, et al.
BMC Family Practice|May 24, 2017
Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008-2015Salima Gasmi, Nicholas H Ogden, Patrick A Leighton, et al.
Industrial Health|February 16, 2013
Climate change and Occupational Health and Safety in a temperate climate: potential impacts and research priorities in Quebec, CanadaAriane Adam-Poupart, France Labrèche, Audrey Smargiassi, et al.
Drug Design, Development and Therapy|December 10, 2015
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinomaJérôme Fayette, Yann Molin, Emilie Lavergne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individualsM G Tovey, J Content, I Gresser, et al.
Head & Neck|November 19, 2019
Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumesFabien Podeur, Pascal Pommier, Carole Crozes, et al.
Intensive Care Medicine|January 1, 1993
Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unitC L de Champs, D P Guelon, R M Garnier, et al.
Plos One|June 4, 2014
Identification of T. gondii myosin light chain-1 as a direct target of TachypleginA-2, a small-molecule inhibitor of parasite motility and invasionJacqueline M Leung, Fanny Tran, Ravindra B Pathak, et al.
Anti-Cancer Drugs|April 2, 2013
Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patientsJérôme Fayette, Nathalie Bonnin, Céline Ferlay, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Role of brachytherapy in treatment of epidermoid carcinomas of the vallecula after conservative supraglottic laryngectomy followed by irradiationSébastien Clippe, Pascal Pommier, Marc Poupart, et al.
Pageof 20

Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
Oncotarget|May 19, 2018
Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME scheduleAdeline Pêtre, Cécile Dalban, Andy Karabajakian, et al.
BMC Family Practice|May 24, 2017
Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008-2015Salima Gasmi, Nicholas H Ogden, Patrick A Leighton, et al.
Industrial Health|February 16, 2013
Climate change and Occupational Health and Safety in a temperate climate: potential impacts and research priorities in Quebec, CanadaAriane Adam-Poupart, France Labrèche, Audrey Smargiassi, et al.
Drug Design, Development and Therapy|December 10, 2015
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinomaJérôme Fayette, Yann Molin, Emilie Lavergne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1988
Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individualsM G Tovey, J Content, I Gresser, et al.
Head & Neck|November 19, 2019
Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumesFabien Podeur, Pascal Pommier, Carole Crozes, et al.
Intensive Care Medicine|January 1, 1993
Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unitC L de Champs, D P Guelon, R M Garnier, et al.
Plos One|June 4, 2014
Identification of T. gondii myosin light chain-1 as a direct target of TachypleginA-2, a small-molecule inhibitor of parasite motility and invasionJacqueline M Leung, Fanny Tran, Ravindra B Pathak, et al.
Anti-Cancer Drugs|April 2, 2013
Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patientsJérôme Fayette, Nathalie Bonnin, Céline Ferlay, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Role of brachytherapy in treatment of epidermoid carcinomas of the vallecula after conservative supraglottic laryngectomy followed by irradiationSébastien Clippe, Pascal Pommier, Marc Poupart, et al.
Pageof 20